Clinical Trial

BCMA CAR-T for Dynamic High-risk Multiple Myeloma

Name: BCMA CAR-T for Dynamic High-risk Multiple Myeloma — clinical trial record (NCT06880393)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CAREMM-003

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is a single-arm, open-label study to evaluate the efficacy and safety of BCMA CAR-T in dynamic high-risk patients with multiple myeloma

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-03-11.

Trial Details

NCT Number	NCT06880393
Lead Sponsor	Institute of Hematology & Blood Diseases Hospital, China
Conditions	Multiple Myeloma
Enrollment	40 participants
Start Date	2025-03-18
Primary Completion	2027-03 (estimated)
Study Completion	2029-03 (estimated)
Updated on ClinicalTrials.gov	2025-08-03